Registered entities
Topas Therapeutics Gmbh
Reg. No. HRB129330Germany
Topas Therapeutics Gmbh
Reg. No. K1101_HRB129330Germany
Innovation
9 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 323 times.
| Year | Filings |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 2 |
Social engagement
Social engagement: 1.9K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
9 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Epidarex Capital, Vesalius Biocapital III, BioMedPartners.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 56% |
| Private equity | 1 | 11% |
| Other / undisclosed | 3 | 33% |
Recent activity
29 Jun 2026
Event
Sixth Newcastle Therapeutic Tolerance Workshop
15 Jun 2026
Event
Sixth Newcastle Therapeutic Tolerance Workshop
13 Apr 2026
Event
Nanotech in Life Science conference